0001382911-15-000002.txt : 20150915 0001382911-15-000002.hdr.sgml : 20150915 20150915141121 ACCESSION NUMBER: 0001382911-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150915 DATE AS OF CHANGE: 20150915 EFFECTIVENESS DATE: 20150915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-247655 FILM NUMBER: 151107491 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0707 D LIVE 0001382911 Orexigen Therapeutics, Inc. 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA CALIFORNIA 92037 (858) 875-8600 DELAWARE None None Corporation true Michael Narachi c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Joseph Hagan c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Thomas Cannell c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Preston Klassen c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Louis C Bock c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Wendy L Dixon c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Brian H. Dovey c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director David J Endicott c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Peter K Honig c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Patrick J Mahaffy c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Lota S Zoth c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Eckard Weber c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06b false 2015-09-10 true true true true false 0 90000000 60000000 30000000 The Total Offering Amount includes the aggregate maximum exercise price of warrants to purchase shares of Common Stock of the Issuer. Such warrants have not yet been exercised. false 1 0 0 0 false Orexigen Therapeutics, Inc. /s/ Joseph Hagan Joseph Hagan EVP, Chief Business & Financial Officer 2015-09-14